Theophylline is able to partially revert cachexia in tumour-bearing rats

Nutrition and Metabolism

Volumn 9, Issue , 2012, Pages

  Olivan, Mireia ^a   Springer, Jochen ^b   Busquets, Sílvia ^a   Tschirner, Anika ^b   Figueras, Maite ^a   Toledo, Miriam ^a   Fontes Oliveira, Cibely ^a   Genovese, Maria Inés ^a   Ventura Da Silva, Paula ^a   Sette, Angelica ^a   López Soriano, Francisco J ^a   Anker, Stefan ^b   Argilés, Josep M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cachexia; Heart; Muscle wasting; Nutraceuticals; Proteolytic system

Indexed keywords

ATROGIN 1; CALPAIN 2; CATHEPSIN B; MUSCLE RING FINGER 1 PROTEIN; THEOPHYLLINE; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCITES HEPATOMA; BODY COMPOSITION; CACHEXIA; CELL CULTURE; CELL LINE; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; HEART FUNCTION; HEART MUSCLE; HYPERTHERMIA; IN VITRO STUDY; MALE; MUSCLE CELL; MUSCLE MASS; NONHUMAN; PROTEIN DEGRADATION; RAT; SOLEUS MUSCLE;

RATTUS;

EID: 84865074747     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-9-76     Document Type: Article

References (38)

1. The immediate causes of death in cancer. Warren S, Am J Med Sci 1932 184 610 615 10.1097/00000441-193211000-00002
2. The metabolic basis of cancer cachexia. Argiles JM, Alvarez B, Lopez-Soriano FJ, Med Res Rev 1997 17 477 498 10.1002/(SICI)1098-1128(199709)17: 5<477::AID-MED3>3.0.CO;2-R 9276862 (Pubitemid 27376498)
3. Management of cancer cachexia. DeWys W, Semin Oncol 1985 12 452 460 3936180
4. The role of cytokines in muscle wasting: its relation with cancer cachexia. Argiles JM, Garcia-Martinez C, Llovera M, Lopez-Soriano FJ, Med Res Rev 1992 12 637 652 10.1002/med.2610120605 1435017
5. DNA fragmentation occurs in skeletal muscle during tumor growth: A link with cancer cachexia? van Royen M, Carbo N, Busquets S, Alvarez B, Quinn LS, Lopez-Soriano FJ, Argiles JM, Biochem Biophys Res Commun 2000 270 533 537 10.1006/bbrc.2000.2462 10753659 (Pubitemid 30446870)
6. Ubiquitin gene expression is increased in skeletal muscle of tumour-bearing rats. Llovera M, Garcia-Martinez C, Agell N, Marzabal M, Lopez-Soriano FJ, Argiles JM, FEBS Lett 1994 338 311 318 10.1016/0014-5793(94) 80290-4 8307200 (Pubitemid 24056743)
7. The ubiquitin-dependent proteolytic pathway in skeletal muscle: its role in pathological states. Argiles JM, Lopez-Soriano FJ, Trends Pharmacol Sci 1996 17 223 226 10.1016/0165-6147(96)10021-3 8763200 (Pubitemid 26191244)
8. Overview of antibacterial, antitoxin, antiviral, and antifungal activities of tea flavonoids and teas. Friedman M, Mol Nutr Food Res 2007 51 116 134 10.1002/mnfr.200600173 17195249 (Pubitemid 46144767)
9. Theophylline-induced mesenteric periarteritis in F344/N rats. Nyska A, Herbert RA, Chan PC, Haseman JK, Hailey JR, Arch Toxicol 1998 72 731 737 10.1007/s002040050567 9879811 (Pubitemid 29001923)
10. Effect of theophylline on induced sputum inflammatory indices and neutrophil chemotaxis in chronic obstructive pulmonary disease. Culpitt SV, de Matos C, Russell RE, Donnelly LE, Rogers DF, Barnes PJ, Am J Respir Crit Care Med 2002 165 1371 1376 10.1164/rccm.2105106 12016098 (Pubitemid 34522939)
11. Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1year. Zhou Y, Wang X, Zeng X, Qiu R, Xie J, Liu S, Zheng J, Zhong N, Ran P, Respirology 2006 11 603 610 10.1111/j.1440-1843.2006. 00897.x 16916334 (Pubitemid 44186267)
12. Anti-inflammatory effects of theophylline: modulation of cytokine production. Mascali JJ, Cvietusa P, Negri J, Borish L, Ann Allergy Asthma Immunol 1996 77 34 38 10.1016/S1081-1206(10)63476-X 8705632 (Pubitemid 26264971)
13. Theophylline and dexamethasone induce peroxisome proliferator-activated receptor-gamma expression in human eosinophils. Usami A, Ueki S, Ito W, Kobayashi Y, Chiba T, Mahemuti G, Oyamada H, Kamada Y, Fujita M, Kato H, Saito N, Kayaba H, Chihara J, Pharmacology 2006 77 33 37 10.1159/000092376 16569937
14. Effects of formoterol on protein metabolism in myotubes during hyperthermia. Ametller E, Busquets S, Fuster G, Figueras MT, De Oliveira CC, Toledo M, Korzeniewska K, Argiles JM, Lopez-Soriano FJ, Muscle Nerve 2011 43 268 273 10.1002/mus.21852 21254094
15. Direct effects of tumor necrosis factor alpha (TNF-alpha) on murine skeletal muscle cell lines. Bimodal effects on protein metabolism. Alvarez B, Quinn LS, Busquets S, Lopez-Soriano FJ, Argiles JM, Eur Cytokine Netw 2001 12 399 410 11566620 (Pubitemid 32905258)
16. Regulation of myosin and overall protein degradation in mouse C2 skeletal myotubes. Gulve EA, Mabuchi K, Dice JF, J Cell Physiol 1991 147 37 45 10.1002/jcp.1041470106 2037623 (Pubitemid 21910080)
17. Theophylline prevents NAD+depletion via PARP-1 inhibition in human pulmonary epithelial cells. Moonen HJ, Geraets L, Vaarhorst A, Bast A, Wouters EF, Hageman GJ, Biochem Biophys Res Commun 2005 338 1805 1810 10.1016/j.bbrc.2005.10.159 16289039 (Pubitemid 41643094)
18. Theophylline in chronic obstructive pulmonary disease: new horizons. Barnes PJ, Proc Am Thorac Soc 2005 2 334 339 discussion 340-331 10.1513/pats.200504-024SR 16267358 (Pubitemid 41699692)
19. Downregulation of ubiquitin-dependent protein degradation in murine myotubes during hyperthermia by eicosapentaenoic acid. Smith HJ, Khal J, Tisdale MJ, Biochem Biophys Res Commun 2005 332 83 88 10.1016/j.bbrc.2005.04.097 15896302 (Pubitemid 40719460)
20. Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting. Busquets S, Figueras MT, Fuster G, Almendro V, Moore-Carrasco R, Ametller E, Argiles JM, Lopez-Soriano FJ, Cancer Res 2004 64 6725 6731 10.1158/0008-5472.CAN-04-0425 15374990 (Pubitemid 39297935)
21. Cancer cachexia, malnutrition, and tissue protein turnover in experimental animals. Tessitore L, Costelli P, Bonetti G, Baccino FM, Arch Biochem Biophys 1993 306 52 58 10.1006/abbi.1993.1479 8215420 (Pubitemid 23291282)
22. Evaluation of a quantitative magnetic resonance method for mouse whole body composition analysis. Tinsley FC, Taicher GZ, Heiman ML, Obes Res 2004 12 150 160 10.1038/oby.2004.20 14742854 (Pubitemid 41137499)
23. No effects of human ghrelin on cardiac function despite profound effects on body composition in a rat model of heart failure. Akashi YJ, Palus S, Datta R, Halem H, Taylor JE, Thoene-Reineke C, Dong J, Thum T, Culler MD, Anker SD, Springer J, Int J Cardiol 2009 137 267 275 10.1016/j.ijcard.2008.06.094 18723230
24. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Chomczynski P, Sacchi N, Anal Biochem 1987 162 156 159 2440339 (Pubitemid 17064313)
25. Resveratrol does not ameliorate muscle wasting in different types of cancer cachexia models. Busquets S, Fuster G, Ametller E, Olivan M, Figueras M, Costelli P, Carbo N, Argiles JM, Lopez-Soriano FJ, Clin Nutr 2007 26 239 244 10.1016/j.clnu.2006.12.001 17261345 (Pubitemid 46477830)
26. Theophylline-induced apoptosis is paralleled by protein kinase A-dependent tissue transglutaminase activation in cancer cells. Caraglia M, Marra M, Giuberti G, DAlessandro AM, Beninati S, Lentini A, Pepe S, Boccellino M, Abbruzzese A, J Biochem 2002 132 45 52 10.1093/oxfordjournals.jbchem.a003197 12097159 (Pubitemid 34832269)
27. Theophylline administration markedly reduces hepatic and pulmonary implantation of B16-F10 melanoma cells in mice. Lentini A, Vidal-Vanaclocha F, Facchiano F, Caraglia M, Abbruzzese A, Beninati S, Melanoma Res 2000 10 435 443 10.1097/00008390-200010000-00005 11095404
28. Regulation of the body fat percentage in developmental-stage rats by methylxanthine derivatives in a high-fat diet. Inoue H, Kobayashi-Hattori K, Horiuchi Y, Oishi Y, Arai S, Takita T, Biosci Biotechnol Biochem 2006 70 1134 1139 10.1271/bbb.70.1134 16717413 (Pubitemid 43765243)
29. Studies of phosphodiesterase effects on adipose tissue metabolism in obese subjects by the microdialysis technique. Flechtner-Mors M, Jenkinson CP, Alt A, Biesalski HK, Adler G, Ditschuneit HH, J Physiol Pharmacol 2005 56 355 368 16204759 (Pubitemid 41406470)
30. Theophylline and selective PDE inhibitors as bronchodilators and smooth muscle relaxants. Rabe KF, Magnussen H, Dent G, Eur Respir J 1995 8 637 642 7664866
31. Cyclic adenosine monophosphate-phosphodiesterase inhibitors reduce skeletal muscle protein catabolism in septic rats. Lira EC, Graca FA, Goncalves DA, Zanon NM, Baviera AM, Strindberg L, Lonnroth P, Migliorini RH, Kettelhut IC, Navegantes LC, Shock 2007 27 687 694 10.1097/SHK.0b013e31802e43a6 17505310 (Pubitemid 46788169)
32. Ca(2+)-dependent proteolysis in muscle wasting. Costelli P, Reffo P, Penna F, Autelli R, Bonelli G, Baccino FM, Int J Biochem Cell Biol 2005 37 2134 2146 10.1016/j.biocel.2005.03.010 15893952 (Pubitemid 41206826)
33. Lipid metabolism in tumour-bearing mice: studies with knockout mice for tumour necrosis factor receptor 1 protein. Lopez-Soriano J, Llovera M, Carbo N, Garcia-Martinez C, Lopez-Soriano FJ, Argiles JM, Mol Cell Endocrinol 1997 132 93 99 10.1016/S0303-7207(97)00125-1 9324050 (Pubitemid 27420303)
34. An investigation of the cause of death from cancer. Houten L, Reilley AA, J Surg Oncol 1980 13 111 116 10.1002/jso.2930130205 7359917 (Pubitemid 10129137)
35. Prevalence and clinical characteristics of a high cardiac output state in patients with multiple myeloma. McBride W, Jackman JD Jr, Grayburn PA, Am J Med 1990 89 21 24 10.1016/0002-9343(90)90092-R 2368788 (Pubitemid 20196708)
36. Glucose uptake and amino acid metabolism in perfused hearts from tumor-bearing rats. Drott C, Lundholm K, J Surg Res 1990 49 62 68 10.1016/0022-4804(90)90112-F 2359296 (Pubitemid 20221417)
37. Novel approaches to the treatment of cachexia. Argiles JM, Lopez-Soriano FJ, Busquets S, Drug Discov Today 2008 13 73 78 10.1016/j.drudis.2007.10.008 18190867
38. Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice. van Norren K, Kegler D, Argiles JM, Luiking Y, Gorselink M, Laviano A, Arts K, Faber J, Jansen H, van der Beek EM, van Helvoort A, Br J Cancer 2009 100 713 722 10.1038/sj.bjc.6604905 19259092